Apollo Ingredients announced the resignation of Ayushi Agarwal as Company Secretary and Compliance Officer. The departure is effective from October 1, 2026, citing personal reasons.

The company filed an intimation with the BSE on September 22, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignation letter was tendered on the same date, September 22, 2026.

Resignation Details

Ayushi Agarwal held membership number A54489. In her resignation letter addressed to the Board of Directors, she confirmed that there were no material reasons for her departure other than those stated. She offered to assist in the smooth transition and handover of duties to her successor.

Regulatory Compliance

The company disclosed that no other listed entities are affected by this change, as Ayushi Agarwal holds no directorship in any other listed company. The Managing Director, Kirit Ghanshyam Mutreja, signed the intimation to the stock exchange. The company has attached the copy of the resignation letter as part of the regulatory filing.

Apollo Ingredients will hold a board meeting on September 22, 2026, to evaluate sustainability initiatives and potential expansion into the healthcare sector. The company previously operated under the name Indsoya Limited.

The Board of Directors scheduled the meeting for 4:00 pm at its registered office in Vasai, Maharashtra. The agenda focuses on strategic growth avenues rather than financial results, indicating a phase of operational planning.

Strategic Agenda Items

The board has listed three primary matters for discussion during the session:

• Environmental Product Declarations (EPDs): The board will discuss implementing EPDs across the value chain to enhance sustainability credentials and market competitiveness.
• Government Contracts: Directors will explore prospects for participating in government tenders to identify new business opportunities.
• Healthcare Diversification: The meeting will address opportunities for backward integration within the healthcare industry to strengthen business capabilities.

Regulatory Context

The intimation was issued pursuant to Regulation 29(1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ayushi Agrawal, Company Secretary and Compliance Officer, signed the notice dated September 17, 2026.

The company maintains manufacturing units in Shrirampur MIDC, Ahmednagar, alongside its registered office in Thane, Palghar.